ArticleScientific reports2025
Explainable multimodal AI for skin lesion risk prediction via 3D imaging and clinical data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence in three-dimensional total-body photography for skin cancer surveillance.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Accurate diagnosis of skin lesions remains challenging due to their morphological variability and the limitations of conventional diagnostic methods. In this study, we developed an explainable artificial intelligence (AI) framework that integrates three-dimensional total body photography (3D TBP) images with structured clinical data to classify and assess the risk of six common skin-lesion types. Using the ISIC 2024 dataset comprising 1,075 patients, 41 clinical and lesion-specific features were extracted and analyzed. A multinomial logistic-regression model was implemented for decision support, and model interpretability was assessed using Shapley Additive Explanations (SHAP) and Class Activation Maps (CAM). The clinical-only XGBoost model achieved moderate accuracy (basal cell carcinoma 78.6%, nevus 72.6%), while CNNs trained on 3D TBP images achieved 87.1% accuracy for nevus. The multimodal fusion model substantially outperformed unimodal approaches, achieving recall and F1 scores above 95% and Area Under the Curve (AUC) values exceeding 0.95 (0.98 for nevus and actinic keratosis), and ranked among the top-performing entries in the ISIC 2024 challenge (partial false-positive rate = 0.1734). The integrated scoring system, visualized through nomograms, identified key predictors such as visual_classifier and tbp_lv_symm_2axis. This interpretable multimodal AI framework enhances diagnostic accuracy and risk stratification, offering a transparent and clinically actionable tool for precision dermatology and early detection of skin cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.